Video

Dr. Putcha on the Use of Blood-Based Screening Assays in CRC

Girish Putcha, MD, PhD, discusses the use of blood-based screening assays in colorectal cancer (CRC).

Girish Putcha, MD, PhD, chief medical officer and clinical laboratory director, Freenome, discusses the use of blood-based screening assays in colorectal cancer (CRC).

The AI-EMERGE study (NCT03688906) utilized a blood-based screening test for early detection of CRC. The prospective, multicenter study enrolled a cohort of 43 asymptomatic patients with average risk and a cohort of 548 patients who served as the study control. The study sought to validate another method of screening in CRC.

The results showed high sensitivity and high specificity with the blood-based test in early-stage and late-stage CRC. These results suggest that the blood-based test, which accounted for tumor-derived and nontumor derived signals, could be a viable strategy for CRC screening in the future, concludes Putcha.

Newsletter

Stay up to date on the most recent and practice-changing oncology data

Latest CME

View All
Community Oncology Connections™: Case Discussions in TNBC…Navigating the Latest Advances and Impact of Disparities in Care | North Carolina
Video

Community Oncology Connections™: Case Discussions in TNBC…Navigating the Latest Advances and Impact of Disparities in Care | North Carolina

Apr 17th 2025 - May 23rd 2025

online-activity
Community Oncology Connections™: Community Oncologists’ Role in Selecting Optimal Oral SERD Treatment for HR+/HER2– Breast Cancer | Minnesota
Video

Community Oncology Connections™: Community Oncologists’ Role in Selecting Optimal Oral SERD Treatment for HR+/HER2– Breast Cancer | Minnesota

Apr 17th 2025 - May 23rd 2025

online-activity
18th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies
Video

18th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies

Apr 8th 2025 - May 14th 2025

online-activity